Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Repare Therapeutics stock
Learn how to easily invest in Repare Therapeutics stock.
Repare Therapeutics Inc is a biotechnology business based in the US. Repare Therapeutics shares (RPTX) are listed on the NASDAQ and all prices are listed in US Dollars. Repare Therapeutics employs 163 staff and has a trailing 12-month revenue of around $8.2 million.
How to buy shares in Repare Therapeutics
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – RPTX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Repare Therapeutics stock price (NASDAQ: RPTX)Use our graph to track the performance of RPTX stocks over time.
Repare Therapeutics shares at a glance
|Latest market close||$12.02|
|52-week range||$8.07 - $28.25|
|50-day moving average||$12.60|
|200-day moving average||$13.86|
|Wall St. target price||$30.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-3.08|
Buy Repare Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Repare Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Repare Therapeutics price performance over time
|1 week (2022-09-20)||N/A|
|1 month (2022-08-30)||3.89%|
|3 months (2022-07-01)||-13.77%|
|6 months (2022-04-01)||-17.10%|
|1 year (2021-10-01)||-54.26%|
|2 years (2020-10-01)||-59.46%|
|3 years (2019-09-27)||N/A|
|5 years (2017-09-27)||N/A|
Repare Therapeutics financials
|Revenue TTM||$8.2 million|
|Gross profit TTM||$-80,254,000|
|Return on assets TTM||-26.64%|
|Return on equity TTM||-56.11%|
|Market capitalisation||$503.3 million|
TTM: trailing 12 months
Repare Therapeutics share dividends
We're not expecting Repare Therapeutics to pay a dividend over the next 12 months.
Repare Therapeutics share price volatility
Over the last 12 months, Repare Therapeutics's shares have ranged in value from as little as $8.065 up to $28.245. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Repare Therapeutics's is -0.1939. This would suggest that Repare Therapeutics's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Repare Therapeutics has bucked the trend.
Repare Therapeutics overview
Repare Therapeutics Inc. , a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada. .
Repare Therapeutics in the news
A Repare Therapeutics Inc. (NASDAQ:RPTX) insider increased their holdings last year
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
Frequently asked questionsWhat percentage of Repare Therapeutics is owned by insiders or institutions?
Currently 5.776% of Repare Therapeutics shares are held by insiders and 90.462% by institutions. How many people work for Repare Therapeutics?
Latest data suggests 163 work at Repare Therapeutics. When does the fiscal year end for Repare Therapeutics?
Repare Therapeutics's fiscal year ends in December. Where is Repare Therapeutics based?
Repare Therapeutics's address is: 7210 Frederick-Banting, Montreal, QC, Canada, H4S 2A1 What is Repare Therapeutics's ISIN number?
Repare Therapeutics's international securities identification number is: US7602731025
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert